Knuff & CO LLC Vertex Pharmaceuticals Inc Transaction History

Knuff & CO LLC

$323 Million
Q3 2024

A detailed history of Knuff & CO LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Knuff & CO LLC holds 14,193 shares of VRTX stock, worth $6.59 Million. This represents 2.04% of its overall portfolio holdings.

Number of Shares

14,193

Previous 14,343 1.05%

Holding current value

$6.59 Million

Previous $6.72 Million 1.81%

% of portfolio

2.04%

Previous 2.2%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$460.0 - $505.78 $69,000 - $75,867	-150 Reduced 1.05%	14,193 $6.6 Million
Q2 2024 Aug 01, 2024	SELL	$392.81 - $485.53 $2,749 - $3,398	-7 Reduced 0.05%	14,343 $6.72 Million
Q1 2024 May 09, 2024	BUY	$407.69 - $446.08 $68,899 - $75,387	169 Added 1.19%	14,350 $6 Million
Q4 2023 Feb 06, 2024	SELL	$343.0 - $410.68 $86,093 - $103,080	-251 Reduced 1.74%	14,181 $5.77 Million
Q3 2023 Nov 09, 2023	SELL	$338.18 - $362.46 $56,814 - $60,893	-168 Reduced 1.15%	14,432 $5.02 Million
Q2 2023 Aug 08, 2023	SELL	$314.42 - $351.91 $119,479 - $133,725	-380 Reduced 2.54%	14,600 $5.14 Million
Q1 2023 May 08, 2023	SELL	$283.23 - $323.1 $332,228 - $378,996	-1,173 Reduced 7.26%	14,980 $4.72 Million
Q4 2022 Feb 09, 2023	SELL	$285.76 - $321.48 $20,288 - $22,825	-71 Reduced 0.44%	16,153 $4.66 Million
Q3 2022 Nov 04, 2022	SELL	$273.83 - $305.53 $291,081 - $324,778	-1,063 Reduced 6.15%	16,224 $4.7 Million
Q2 2022 Aug 08, 2022	SELL	$234.96 - $292.55 $88,110 - $109,706	-375 Reduced 2.12%	17,287 $4.87 Million
Q1 2022 May 10, 2022	BUY	$221.42 - $260.97 $3,542 - $4,175	16 Added 0.09%	17,662 $4.61 Million
Q4 2021 Feb 09, 2022	BUY	$177.01 - $223.45 $112,224 - $141,667	634 Added 3.73%	17,646 $3.88 Million
Q3 2021 Nov 16, 2021	BUY	$181.39 - $202.99 $24,306 - $27,200	134 Added 0.79%	17,012 $3.09 Million
Q2 2021 Aug 10, 2021	BUY	$187.49 - $221.1 $19,686 - $23,215	105 Added 0.63%	16,878 $3.4 Million
Q1 2021 May 04, 2021	BUY	$207.02 - $241.31 $9,108 - $10,617	44 Added 0.26%	16,773 $3.6 Million
Q4 2020 Feb 03, 2021	BUY	$207.01 - $276.09 $1.39 Million - $1.85 Million	6,700 Added 66.81%	16,729 $3.95 Million
Q3 2020 Nov 03, 2020	BUY	$255.65 - $303.1 $277,124 - $328,560	1,084 Added 12.12%	10,029 $2.73 Million
Q2 2020 Aug 07, 2020	BUY	$225.48 - $295.8 $169,786 - $222,737	753 Added 9.19%	8,945 $2.6 Million
Q1 2020 May 13, 2020	SELL	$199.77 - $247.81 $3,196 - $3,964	-16 Reduced 0.19%	8,192 $1.95 Million
Q4 2019 Feb 11, 2020	BUY	$166.71 - $223.91 $115,530 - $155,169	693 Added 9.22%	8,208 $1.8 Million
Q3 2019 Nov 05, 2019	BUY	$166.23 - $187.09 $168,723 - $189,896	1,015 Added 15.62%	7,515 $1.27 Million
Q2 2019 Aug 08, 2019	BUY	$164.61 - $190.37 $69,959 - $80,907	425 Added 7.0%	6,500 $1.19 Million
Q1 2019 May 08, 2019	BUY	$163.73 - $194.7 $75,315 - $89,562	460 Added 8.19%	6,075 $1.12 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $852,974 - $1.08 Million	5,615 New	5,615 $930,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Knuff & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knuff & CO LLC with notifications on news.

Account